Calimmune, Inc. Report issue

For profit Phase 2
Founded: Tuscon AZ United States (2000)
Status: Acquired by CSL Behring (2017)

Organization Overview

First Clinical Trial
2013
NCT01734850
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree